Empaglyn L 10mg/5mg Tablet 10s

Introduction to Empaglyn L 10mg/5mg Tablet 10s

Empaglyn L 10mg/5mg Tablet 10s is a combination medication in tablet form primarily used for managing type 2 diabetes. This medicine is prescribed when diet and exercise alone are insufficient to control blood sugar levels. Empaglyn L 10mg/5mg Tablet 10s may also provide additional benefits for heart health and kidney protection in individuals with type 2 diabetes.

Composition of Empaglyn L 10mg/5mg Tablet 10s

Empaglyn L 10mg/5mg Tablet 10s contains two active ingredients: Empagliflozin (10mg) and Linagliptin (5mg). Empagliflozin works by helping the kidneys remove excess glucose from the bloodstream through urine, effectively lowering blood sugar levels. Linagliptin increases insulin production and decreases sugar production in the liver, providing a complementary approach to managing blood sugar levels.

Uses of Empaglyn L 10mg/5mg Tablet 10s

• Management of type 2 diabetes
• Potential benefits for heart health
• Kidney protection in type 2 diabetes patients

Side effects of Empaglyn L 10mg/5mg Tablet 10s

• Common side effects: Urinary tract infections, increased urination, runny nose, sore throat
• Serious side effects: Low blood sugar, especially when taken with other diabetes medications

Precautions of Empaglyn L 10mg/5mg Tablet 10s

Empaglyn L 10mg/5mg Tablet 10s should not be used in individuals with severe kidney problems or those on dialysis. Linagliptin is not recommended for people with a history of pancreatitis. Caution is advised for those with low blood pressure or dehydration.

How to Take Empaglyn L 10mg/5mg Tablet 10s

Empaglyn L 10mg/5mg Tablet 10s is taken orally, typically as a 10 mg dose of Empagliflozin and a 5 mg dose of Linagliptin once daily. It can be taken with or without food. Always follow your healthcare provider's instructions for the correct dosage and administration.

Conclusion of Empaglyn L 10mg/5mg Tablet 10s

Empaglyn L 10mg/5mg Tablet 10s, manufactured by Zydus Healthcare Ltd, is a combination of Empagliflozin and Linagliptin used in the therapeutic class of diabetes management. It is primarily used for managing type 2 diabetes and may offer additional heart and kidney benefits. Always consult your healthcare provider for personalized advice and follow their instructions for optimal results.